Terazosin hydrochloride
Terazosin is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH) . It also acts to lower blood pressure, so it is a drug of choice for men with hypertension and prostate enlargement. It works by blocking the action of adrenaline on smooth muscle of the bladder and the blood vessel walls. (In Vitro) :Terazosin does not discriminate cloned α1-adrenoceptor subtypes transiently expressed in COS cells. (In Vivo) :Terazosin can be used to promote stone discharge in treatment of ureteral stones. Terazosin is reportedly safe and effective in treatment of distal ureteral stones, especially stones >5 mm.
Product Specifications
CAS Number
63074-08-8
Product Name Alternative
Terazocin HCl | Vasocard | Hyprin | A-45975 | A 45975 | A45975
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
Water: 50 mM
Smiles
O=C (N1CCN (C2=NC (N) =C3C=C (OC) C (OC) =CC3=N2) CC1) C4OCCC4.[H]Cl
Molecular Formula
C19H26ClN5O4
Molecular Weight
423.89
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Piperazine, 1- (4-amino-6,7-dimethoxy-2-quinazolinyl) -4- ((tetrahydro-2-furanyl) carbonyl) -, monohydrochloride
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog